Medicare Enrolled

Dr. James Charles, M.D.

Optician · Bayonne, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
956 KENNEDY BLVD, Bayonne, NJ 07002
2018582457
In practice since 2006 (19 years)
NPI: 1356457246 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Charles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Charles? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Charles

Dr. James Charles is an optician specialist in Bayonne, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Charles performed 5,956 Medicare services across 374 unique beneficiaries.

Between the years covered by Open Payments, Dr. Charles received a total of $151,454 from 68 pharmaceutical and/or device companies across 1405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Charles is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in NJ $151,454 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,956
Medicare services
Top 11% in NJ for optician
374
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~313 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
5,502 $5 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
145 $111 $201
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
76 $71 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
53 $78 $175
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
51 $157 $225
New patient office visit, complex (60-74 min) 45 $188 $351
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
25 $143 $287
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
24 $82 $250
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
18 $13 $61
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
17 $90 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$151,454
Total received (2018-2024)
Avg $21,636/year across 7 years
Top 2% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
1,405
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$138,646 (91.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,807 (8.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,528
2023
$11,292
2022
$26,573
2021
$43,942
2020
$13,704
2019
$21,539
2018
$26,877

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$5,049
PFIZER INC.
$466
Lundbeck LLC
$315
Teva Pharmaceuticals USA, Inc.
$305
Amneal Pharmaceuticals LLC
$257
EMD Serono, Inc.
$252
Axsome Therapeutics, Inc.
$158
Kyowa Kirin, Inc.
$112
Neurocrine Biosciences, Inc.
$83
Celgene Corporation
$81
Lilly USA, LLC
$67
SK Life Science, Inc.
$66
ARGENX US, INC.
$60
UCB, Inc.
$59
Biogen, Inc.
$57
Genentech USA, Inc.
$33
Alexion Pharmaceuticals, Inc.
$17
ACADIA Pharmaceuticals Inc
$16
Amgen Inc.
$16
SCILEX PHARMACEUTICALS INC.
$16
Harmony Biosciences Llc
$15
Novartis Pharmaceuticals Corporation
$15
Grifols USA, LLC
$14
Top 3 companies account for 77.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$45,860
Biohaven Pharmaceuticals, Inc.
$20,426
Teva Pharmaceuticals USA, Inc.
$15,765
AbbVie Inc.
$12,714
ABBVIE INC.
$12,043
Allergan, Inc.
$9,218
Biohaven Pharmaceutical Holding Company Ltd.
$9,016
Supernus Pharmaceuticals, Inc.
$8,238
Assertio Therapeutics, Inc.
$6,562
Lundbeck LLC
$1,964
EMD Serono, Inc.
$898
Biogen, Inc.
$841
Amneal Pharmaceuticals LLC
$805
PFIZER INC.
$664
Lilly USA, LLC
$500
UCB, Inc.
$491
Allergan Inc.
$454
US WorldMeds, LLC
$381
Kyowa Kirin, Inc.
$311
Axsome Therapeutics, Inc.
$301
SK Life Science, Inc.
$271
Eisai Inc.
$256
Novartis Pharmaceuticals Corporation
$226
Genentech USA, Inc.
$222
Acorda Therapeutics, Inc
$212
JAZZ PHARMACEUTICALS INC.
$211
NOVARTIS PHARMACEUTICALS CORPORATION
$203
ACADIA Pharmaceuticals Inc
$180
Celgene Corporation
$167
MDD US Operations, LLC
$153
Alexion Pharmaceuticals, Inc.
$144
BANNER LIFE SCIENCES, LLC
$125
ARGENX US, INC.
$124
Neurocrine Biosciences, Inc.
$110
UPSHER-SMITH LABORATORIES LLC
$103
Impax Laboratories, Inc.
$96
EISAI INC.
$93
Merck Sharp & Dohme LLC
$71
Upsher-Smith Laboratories LLC
$70
Avanir Pharmaceuticals, Inc.
$68
Currax Pharmaceuticals LLC
$68
Pernix Therapeutics Holdings, Inc.
$67
Janssen Pharmaceuticals, Inc
$56
Adamas Pharmaceuticals, Inc.
$54
Bausch Health US, LLC
$53
Grifols USA, LLC
$53
GE HealthCare
$50
Mallinckrodt LLC
$49
Collegium Pharmaceutical, Inc.
$43
Scilex Pharmaceuticals Inc.
$40
E.R. Squibb & Sons, L.L.C.
$39
Mallinckrodt Enterprises LLC
$37
Mallinckrodt Hospital Products Inc.
$29
Otsuka America Pharmaceutical, Inc.
$28
Avion Pharmaceuticals
$27
ASSERTIO THERAPEUTICS, Inc.
$26
TG THERAPEUTICS, INC.
$22
BOSTON SCIENTIFIC CORPORATION
$19
SCILEX PHARMACEUTICALS INC.
$16
Harmony Biosciences Llc
$15
Vertical Pharmaceuticals, LLC
$15
Almatica Pharma LLC
$15
Harmony Biosciences LLC
$15
TerSera Therapeutics LLC
$14
Merck Sharp & Dohme Corporation
$12
Neurelis, Inc.
$12
Egalet US Inc
$11
Sumitomo Pharma America, Inc.
$10
Top 3 companies account for 54.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · Cambia · Cenobamate · DUOPA · Dhivy · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · ERGOMAR · Enspryng · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LINZESS · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · PANZYGA · PAXLOVID · QULIPTA · REXULTI · RYTARY · SILENOR · SOLIRIS · SPRIX · SUNOSI · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREXIMET · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · WELLBUTRIN XL · Wakix · XADAGO · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOHYDRO ER · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for optician in NJ.

Looking for an optician specialist in Bayonne?
Compare opticians in the Bayonne area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
13,917
Per 100K population
1958.8
County median income
$90,032
Nearest hospital
CAREPOINT HEALTH - BAYONNE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Charles is a mixed practice specialist, with above-average Medicare volume (top 11% in NJ), with speaking/promotional industry engagement in the top 2% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Charles experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Charles performed 5,502 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Charles receive payments from pharmaceutical companies?
Yes. Dr. Charles received a total of $151,454 from 68 companies across 1,405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Charles's costs compare to other opticians in Bayonne?
Dr. Charles's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Charles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →